• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

根据 2004 年世界卫生组织分类,输尿管镜活检和尿细胞学检查低估了上尿路尿路上皮癌的肿瘤分级。

Ureterorenoscopic biopsy and urinary cytology according to the 2004 WHO classification underestimate tumor grading in upper urinary tract urothelial carcinoma.

机构信息

Department of Urology, Groβhadern University Hospital, Ludwig Maximilians University of Munich, Munich, Germany.

出版信息

Urol Oncol. 2013 Oct;31(7):1166-70. doi: 10.1016/j.urolonc.2011.12.021. Epub 2012 Jan 31.

DOI:10.1016/j.urolonc.2011.12.021
PMID:22300757
Abstract

OBJECTIVES

To determine accuracy of upper tract cytology and ureteroscopic biopsy according to the 2004 World Health Organization (WHO) classification in predicting the correct tumor grade in patients with urothelial cancer of the upper urinary tract (UUT-UC).

METHODS

Pathology reports of 77 nephroureterectomy specimens were retrospectively analyzed for tumor grade and compared with preoperatively gained cytology and ureteroscopic biopsy results. For analysis, the 2004 WHO classification was used.

RESULTS

Overall sensitivity of cytology and biopsy in diagnosis of UUT-UC was 64% and 74%, respectively. Accuracy of cytology and biopsy in predicting high grade cancer was 53% and 58%, respectively. Combination of cytology and biopsy could improve sensitivity (84%) and accuracy (68%), but even for this combination, 15% of high grade tumors were misinterpreted as low grade cancer.

CONCLUSION

Our results show only limited accuracy for preoperative cytology and ureterorenoscopically performed biopsies in the prediction of the correct tumor grading of an UUT-UC. Therefore, we suggest the use of additional diagnostic procedures before the decision for definitive surgical treatment in patients with UUT-UC is made.

摘要

目的

根据 2004 年世界卫生组织(WHO)分类,确定上尿路尿路上皮癌(UUT-UC)患者上尿路细胞学和输尿管镜活检预测正确肿瘤分级的准确性。

方法

回顾性分析 77 例肾输尿管切除术标本的病理学报告,比较术前细胞学和输尿管镜活检结果。分析采用 2004 年 WHO 分类。

结果

细胞学和活检诊断 UUT-UC 的总体敏感性分别为 64%和 74%。细胞学和活检预测高级别癌症的准确性分别为 53%和 58%。细胞学和活检的联合应用可提高敏感性(84%)和准确性(68%),但即使联合应用,仍有 15%的高级别肿瘤被误诊为低级别癌症。

结论

我们的结果表明,术前细胞学和输尿管镜下活检在预测 UUT-UC 的正确肿瘤分级方面仅有有限的准确性。因此,我们建议在决定对 UUT-UC 进行确定性手术治疗之前,使用其他诊断程序。

相似文献

1
Ureterorenoscopic biopsy and urinary cytology according to the 2004 WHO classification underestimate tumor grading in upper urinary tract urothelial carcinoma.根据 2004 年世界卫生组织分类,输尿管镜活检和尿细胞学检查低估了上尿路尿路上皮癌的肿瘤分级。
Urol Oncol. 2013 Oct;31(7):1166-70. doi: 10.1016/j.urolonc.2011.12.021. Epub 2012 Jan 31.
2
Low biopsy volume in ureteroscopy does not affect tumor biopsy grading in upper tract urothelial carcinoma.经尿道输尿管镜检查的活检样本量低不会影响上尿路尿路上皮癌的肿瘤活检分级。
Urol Oncol. 2013 Nov;31(8):1696-700. doi: 10.1016/j.urolonc.2012.05.010. Epub 2012 Jul 21.
3
Diagnostic accuracy of upper tract urothelial carcinoma: how samples are collected matters.上尿路尿路上皮癌的诊断准确性:样本采集方式至关重要。
Scand J Urol. 2017 Apr;51(2):137-145. doi: 10.1080/21681805.2017.1295102. Epub 2017 Apr 7.
4
The Paris System for urine cytology in upper tract urothelial specimens: A comparative analysis with biopsy and surgical resection.上尿路尿路上皮标本的巴黎尿液细胞学系统:与活检和手术切除的比较分析
Cytopathology. 2018 Apr;29(2):184-188. doi: 10.1111/cyt.12505. Epub 2017 Dec 18.
5
Pathologic features of bladder tumors after nephroureterectomy or segmental ureterectomy for upper urinary tract transitional cell carcinoma.上尿路移行细胞癌行肾输尿管切除术或输尿管节段切除术后膀胱肿瘤的病理特征。
Urology. 2007 Feb;69(2):251-4. doi: 10.1016/j.urology.2006.09.065.
6
Can we improve the biopsy quality of upper urinary tract urothelial tumors? Single-center preliminary results of a new biopsy forceps.我们能否提高上尿路尿路上皮肿瘤的活检质量?一种新型活检钳的单中心初步结果。
Urol Int. 2014;93(1):34-7. doi: 10.1159/000354875. Epub 2014 Mar 15.
7
Predictive factors for bladder recurrence after radical nephroureterectomy for upper urinary tract urothelial carcinoma.上尿路尿路上皮癌根治性肾输尿管切除术后膀胱复发的预测因素。
Urol Int. 2013;91(2):153-9. doi: 10.1159/000346086. Epub 2013 Feb 5.
8
Clinical utility and concordance of upper urinary tract cytology and biopsy in predicting clinicopathological features of upper urinary tract urothelial carcinoma.上尿路尿路上皮癌临床病理特征的预测中,上尿路细胞学和活检的临床实用性和一致性。
Hum Pathol. 2019 Apr;86:76-84. doi: 10.1016/j.humpath.2018.11.021. Epub 2018 Dec 8.
9
Cytologic evaluation of upper urinary tract specimens: An institutional retrospective study using The Paris System for Reporting Urine Cytology second edition with histopathologic follow-up.上尿路标本的细胞学评估:采用第二代巴黎尿细胞学报告系统(附组织病理学随访)的机构回顾性研究。
Cytopathology. 2024 Mar;35(2):235-241. doi: 10.1111/cyt.13328. Epub 2023 Nov 2.
10
Indications for ureteropyeloscopy based on radiographic findings and urine cytology in detection of upper urinary tract carcinoma.基于影像学表现和尿液细胞学检查在上尿路癌诊断中的输尿管肾盂镜检查适应证。
Jpn J Clin Oncol. 2010 Nov;40(11):1087-91. doi: 10.1093/jjco/hyq096. Epub 2010 Jun 24.

引用本文的文献

1
BRAF Mutation Analysis: A Retrospective Evaluation of 8365 Diagnostic Samples with a Special View on Canine Breeds (2018-2024).BRAF 突变分析:对8365份诊断样本的回顾性评估,特别关注犬种(2018 - 2024年)
Vet Sci. 2025 Aug 2;12(8):729. doi: 10.3390/vetsci12080729.
2
Clinical utility of urinary comprehensive genomic profiling in diagnosing metachronous upper tract urothelial carcinoma: a case report.尿液综合基因组分析在诊断异时性上尿路尿路上皮癌中的临床应用:一例报告
Front Urol. 2023 Aug 9;3:1229709. doi: 10.3389/fruro.2023.1229709. eCollection 2023.
3
Head-to-head comparisons of Ga-PSMA-11 and F-FDG PET/CT in evaluating patients with upper tract urothelial carcinoma: a prospective pilot study.
镓-PSMA-11与氟代脱氧葡萄糖PET/CT在评估上尿路尿路上皮癌患者中的头对头比较:一项前瞻性初步研究。
Int Urol Nephrol. 2023 Nov;55(11):2753-2764. doi: 10.1007/s11255-023-03710-1. Epub 2023 Jul 21.
4
Validation of a Liquid Biopsy Protocol for Canine BRAFV595E Variant Detection in Dog Urine and Its Evaluation as a Diagnostic Test Complementary to Cytology.用于检测犬尿液中犬BRAFV595E变异体的液体活检方案的验证及其作为细胞学补充诊断测试的评估。
Front Vet Sci. 2022 May 31;9:909934. doi: 10.3389/fvets.2022.909934. eCollection 2022.
5
Free Ferrous Protoporphyrin and Reactive Oxygen Species Status of Voided Urine Predicts Higher Stage in Urothelial Carcinoma.晨尿中游离亚铁原卟啉和活性氧状态可预测尿路上皮癌的更高分期。
Cancer Manag Res. 2022 Feb 15;14:615-621. doi: 10.2147/CMAR.S352127. eCollection 2022.
6
Outcomes of endoscopic management of upper tract urothelial carcinoma.上尿路尿路上皮癌的内镜治疗结果
Transl Androl Urol. 2020 Aug;9(4):1821-1830. doi: 10.21037/tau.2019.12.26.
7
Management of Low-grade Upper Tract Urothelial Carcinoma: An Unmet Need.低级别上尿路尿路上皮癌的管理:一项未满足的需求。
Rev Urol. 2020;22(1):1-8.
8
Confocal laser endomicroscopy for upper tract urothelial carcinoma: validation of the proposed criteria and proposal of a scoring system for real-time tumor grading.共聚焦激光内镜检查在上尿路尿路上皮癌中的应用:验证拟议标准并提出实时肿瘤分级评分系统。
World J Urol. 2019 Oct;37(10):2155-2164. doi: 10.1007/s00345-019-02646-5. Epub 2019 Jan 25.
9
Ex-vivo Imaging of Upper Tract Urothelial Carcinoma Using Novel pH Low Insertion Peptide (Variant 3), a Molecular Imaging Probe.使用新型 pH 低插入肽(变体 3),一种分子成像探针,对上尿路尿路上皮癌进行离体成像。
Urology. 2020 May;139:134-140. doi: 10.1016/j.urology.2019.01.008. Epub 2019 Jan 16.
10
[Biopsy techniques in the upper urinary tract for the diagnosis of urothelial carcinoma: systematic review].[上尿路尿路上皮癌诊断的活检技术:系统评价]
Urologe A. 2019 Jan;58(1):14-21. doi: 10.1007/s00120-018-0829-6.